Family Medicine Doctors in Countryside, IL Accepting Medicare
4 Family Medicine doctors found. Showing 1 - 4
 Dr. Michael David Santilli, DO Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 7345 Prescott Ln, Countryside, IL 60525 Phone: 708-354-9405 Fax: 708-354-9140 |
Dr. Christopher Brenner, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 9910 W 55th St, Countryside, IL 60525 Phone: 708-352-6166 Fax: 708-352-3864 |
 Allison K Shewmake, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6700 S Brainard Ave Apt 421, Countryside, IL 60525 Phone: 630-660-3992 |
Dr. Stacey L Carpenter, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6150 Joliet Rd, Countryside, IL 60525 Phone: 708-485-2273 Fax: 708-352-0845 |
News Archive
Mutations in ion channels cause rare inherited pain disorder: Research
A mutation that enhances the function of a specific ion channel has been identified as the cause of a rare inherited pain disorder. The research, published by Cell Press in the June 10 issue of the journal Neuron, proposes a potential treatment for the disorder and may lead to a better understanding of chronic pain in humans.
Cardiac Science and Cambridge Heart team up to develop MTWA module
Cardiac Science Corporation [NASDAQ: CSCX], a global leader in automated external defibrillator (AED) and diagnostic cardiac monitoring devices, and Cambridge Heart, Inc., [OTCBB-CAMH], a developer of noninvasive diagnostic tests for cardiac disease, with a focus on identifying those at risk for sudden cardiac arrest, today announced a partnership pursuant to a Development, Supply and Distribution Agreement Cambridge Heart previously announced on June 23, 2009.
Endo Pharmaceuticals reaches patent litigation settlement with LecTec
Endo Pharmaceuticals announced today that it has reached a settlement with LecTec Corporation on outstanding patent litigation related to LecTec's U.S. Patent Nos. 5,536,263 and 5,741,510.
Boston Scientific launches ION Paclitaxel-Eluting Platinum Chromium Coronary Stent System
Boston Scientific Corporation today announced U.S. Food and Drug Administration (FDA) approval and launch of the ION™ Paclitaxel-Eluting Platinum Chromium Coronary Stent System, the Company's third-generation drug-eluting stent technology.
› Verified 2 days ago
Family Medicine
Pediatrics
Psychiatry & Neurology
Internal Medicine
Geriatric Medicine